Company Analysis CSL Limited
1. Summary
Advantages
- Current debt level 32.04% is below 100% and has decreased over 5 years from 37.68%.
- The company's current efficiency (ROE=15.94%) is higher than the sector average (ROE=12.46%)
Disadvantages
- Price (77.5 $) is higher than fair price (32.52 $)
- Dividends (1.41%) are below the sector average (2.28%).
- The stock's return over the last year (-25.76%) is lower than the sector average (4.54%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
CSL Limited | Healthcare | Index | |
---|---|---|---|
7 days | -1.8% | 0% | 0.7% |
90 days | 0% | -1.1% | 22.1% |
1 year | -25.8% | 4.5% | 12.9% |
CSLLY vs Sector: CSL Limited has significantly underperformed the "Healthcare" sector by -30.3% over the past year.
CSLLY vs Market: CSL Limited has significantly underperformed the market by -38.68% over the past year.
Stable price: CSLLY is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: CSLLY with weekly volatility of -0.4954% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (77.5 $) is higher than the fair price (32.52 $).
Price is higher than fair: The current price (77.5 $) is 58% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (35.68) is lower than that of the sector as a whole (54.24).
P/E vs Market: The company's P/E (35.68) is lower than that of the market as a whole (59.87).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (4.86) is higher than that of the sector as a whole (4.2).
P/BV vs Market: The company's P/BV (4.86) is higher than that of the market as a whole (3.17).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (6.42) is higher than that of the sector as a whole (4.62).
P/S vs Market: The company's P/S indicator (6.42) is higher than that of the market as a whole (3.43).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (22.14) is higher than that of the sector as a whole (14.71).
EV/Ebitda vs Market: The company's EV/Ebitda (22.14) is lower than that of the market as a whole (40.12).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 5.13% over the last 5 years.
Earnings Slowdown: The last year's return (0%) is below the 5-year average return (5.13%).
Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (0.5351%).
5.4. ROE
ROE vs Sector: The company's ROE (15.94%) is higher than that of the sector as a whole (12.46%).
ROE vs Market: The company's ROE (15.94%) is lower than that of the market as a whole (41.73%).
5.5. ROA
ROA vs Sector: The company's ROA (7.11%) is higher than that of the sector as a whole (6.23%).
ROA vs Market: The company's ROA (7.11%) is lower than that of the market as a whole (29.55%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (15.5%) is higher than that of the sector as a whole (15.34%).
ROIC vs Market: The company's ROIC (15.5%) is higher than that of the market as a whole (10.99%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 1.41% is below the average for the sector '2.28%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 1.41% has been steadily paid over the past 7 years, DSI=1.
Dividend growth: Company's dividend yield 1.41% has been growing over the last 5 years. Growth over 13 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (47.92%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription